Online citations, reference lists, and bibliographies.
← Back to Search

Predicting The Clinical Status Of Human Breast Cancer By Using Gene Expression Profiles

M. West, C. Blanchette, H. Dressman, E. Huang, S. Ishida, R. Spang, H. Zuzan, J. Olson, J. Marks, J. Nevins
Published 2001 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Prognostic and predictive factors are indispensable tools in the treatment of patients with neoplastic disease. For the most part, such factors rely on a few specific cell surface, histological, or gross pathologic features. Gene expression assays have the potential to supplement what were previously a few distinct features with many thousands of features. We have developed Bayesian regression models that provide predictive capability based on gene expression data derived from DNA microarray analysis of a series of primary breast cancer samples. These patterns have the capacity to discriminate breast tumors on the basis of estrogen receptor status and also on the categorized lymph node status. Importantly, we assess the utility and validity of such models in predicting the status of tumors in crossvalidation determinations. The practical value of such approaches relies on the ability not only to assess relative probabilities of clinical outcomes for future samples but also to provide an honest assessment of the uncertainties associated with such predictive classifications on the basis of the selection of gene subsets for each validation analysis. This latter point is of critical importance in the ability to apply these methodologies to clinical assessment of tumor phenotype.
This paper references
10.1002/(SICI)1097-4695(20000605)43:3<269::AID-NEU5>3.0.CO;2-D
Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats.
G. P. Cardona-Gómez (2000)
Gene-expression profiles in hereditary breast cancer.
J. Sudbø (2001)
10.1073/PNAS.97.18.10101
Singular value decomposition for genome-wide expression data processing and modeling.
O. Alter (2000)
10.1093/hmg/9.20.2981
Gene expression profiling of primary breast carcinomas using arrays of candidate genes.
F. Bertucci (2000)
10.1074/JBC.M008201200
Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex
D. Prévôt (2001)
10.1073/PNAS.96.12.6745
Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.
U. Alon (1999)
10.1093/NAR/15.4.1401
Structure of the human oestrogen-responsive gene pS2.
J. M. Jeltsch (1987)
Linking gene expression patterns to therapeutic groups in breast cancer.
K. Martin (2000)
Bayesian Regression Analysis in the "Large p, Small n" Paradigm with Application in DNA Microarray S
M. West (2000)
Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.
L. L. Shek (1988)
10.1097/00000658-199904000-00012
Lessons learned from 500 cases of lymphatic mapping for breast cancer.
A. Hill (1999)
10.1073/PNAS.96.16.9212
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
C. Perou (1999)
10.1002/9780470514757.CH15
Oestrogen- and anti-oestrogen-regulated genes in human breast cancer.
H. Rochefort (1995)
10.1200/JCO.1989.7.8.1120
HER-2/neu oncogene protein and prognosis in breast cancer.
A. K. Tandon (1989)
10.1038/35020115
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M. Bittner (2000)
10.1056/NEJM199405053301802
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
H. Muss (1994)
10.1038/35000501
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh (2000)
Gene expression profiles in hereditary breast cancer
I Hedenfalk (2001)
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.
J. Khan (1998)
10.1210/endo.139.10.6229
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells* * This work was supported by Grants NIH-RO-1-65622-04 (to R.J.S.), HD-25719 (to M.A.S.), GM-55985 and CA-44579 (to T.P.B.), and CA-65746 (to R.K.).
Meei-Huey Jeng (1998)
10.1016/S0304-3835(00)00466-3
Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms.
Z. Shao (2000)
10.1111/j.1440-1681.1998.tb02257.x
EVIDENCE FOR THE PRESENCE OF BOTH P1 AND P2 PURINOCEPTORS IN THE RAT MYOMETRIUM
T. Gillman (1998)
51 involvement in estrogen receptor (alpha) signaling pathway
Prevot (2001)
10.1038/NG1296-457
Use of a cDNA microarray to analyse gene expression patterns in human cancer
J. DeRisi (1996)
estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin−like growth factor binding protein 2
R. S. Richmond (2000)
10.1210/en.139.10.4164
Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
M. H. Jeng (1998)
10.1126/SCIENCE.8290962
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.
Z. Zou (1994)
correlation with estrogen receptor expression and prognosis in node− negative breast cancer
Gilbert (1993)
Serological detection of heat shock protein hsp27 in normal and breast cancer patients.
M. Fanelli (1998)
10.1002/BJS.1800720511
Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer
J. Kjaergaard (1985)
Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
J. Gudas (1995)
Bayesian Data Analysis Ref Type: Serial (Book,Monograph) 25
J B Carlin (1987)
10.1073/PNAS.93.21.11669
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
S. Sheng (1996)
class discovery and class prediction by gene expression monitoring
Golub (1999)
10.2307/2533081
Bayesian Data Analysis
A. Gelman (1995)
10.1074/JBC.M002726200
Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin.
D. Robyr (2000)
10.2307/2669495
Ordinal Data Modeling
V. E. Johnson (2000)
Lessons learned from 500 cases of lymphatic mapping for breast cancer
Hill (1999)
10.1073/PNAS.96.7.3700
Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells.
Ge Xiao (1999)
relation to axillary lymph node metastasis
Pitton (1989)
10.1126/SCIENCE.286.5439.531
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T. Golub (1999)
10.1073/PNAS.86.4.1218
Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.
M. Berry (1989)
10.1200/JCO.1993.11.1.49
A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer.
L. Gilbert (1993)
10.1002/1529-0131(200009)43:9<2081::AID-ANR20>3.0.CO;2-I
Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2.
R. S. Richmond (2000)
10.1097/00000658-200001000-00021
Sentinel node biopsy in breast cancer.
R. Bold (2000)
effects of estrogen and bromocriptine
Matsuno (1997)
Augmentation of tumor metastasis by platelet-activating factor.
S. Y. Im (1996)
10.1093/NAR/27.6.1517
Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes.
G. Yang (1999)
10.1038/sj.onc.1204006
Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice
M. Zhang (2000)
10.1093/JNCI/81.17.1298
Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis.
C. Pitton (1989)
10.1016/S0303-7207(00)00279-3
Interactions between androgen and estrogen receptors and the effects on their transactivational properties
V. Panet-Raymond (2000)
10.1074/JBC.275.15.11141
Interaction in Vivo and in Vitro of the Metastasis-inducing S100 Protein, S100A4 (p9Ka) with S100A1*
G. Wang (2000)
10.1177/002215549704500605
Modulation of Protein Kinases and Microtubule-associated Proteins and Changes in Ultrastructure in Female Rat Pituitary Cells: Effects of Estrogen and Bromocriptine
A. Matsuno (1997)
10.1046/J.1432-1327.1998.2520147.X
Induction of aromatase activity in human adipose tissue stromal cells by extracellular nucleotides--evidence for P2-purinoceptors in adipose tissue.
M. Schmidt (1998)
10.1016/S0039-6060(98)70122-9
Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
C. Carmeci (1998)
10.1002/(SICI)1096-9896(199708)182:4<404::AID-PATH875>3.0.CO;2-0
Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells
F. May (1997)
10.1002/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S
GATA‐3 is expressed in association with estrogen receptor in breast cancer
R. Hoch (1999)
10.1093/JNCI/84.16.1279
Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers.
D. Ciocca (1992)
10.1016/0303-7207(96)03844-0
Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells
M. K. El-Tanani (1996)



This paper is referenced by
10.1039/c0an00667j
Noise incorporated subwindow permutation analysis for informative gene selection using support vector machines.
Q. Wang (2011)
10.1093/bioinformatics/btl632
Clustering threshold gradient descent regularization: with applications to microarray studies
S. Ma (2007)
10.1200/JCO.2002.20.7.1932
DNA microarrays in clinical oncology.
S. Ramaswamy (2002)
Feature Selection via Dependence Maximization
L. Song (2012)
10.1109/ICASSP.2014.6854463
Non-uniform feature sampling for decision tree ensembles
Anastasios Kyrillidis (2014)
10.1186/1471-2105-9-63
Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation
D. Smith (2007)
10.1007/978-1-60327-088-5_16
Microarray Profiling in Breast Cancer Patients
Y. Qian (2008)
10.1109/TPAMI.2010.215
Feature Selection and Kernel Learning for Local Learning-Based Clustering
Hong Zeng (2011)
10.3892/OL.2018.9799
Moesin is an independent prognostic marker for ER-positive breast cancer.
Lifeng Yu (2019)
10.1109/TPAMI.2015.2478471
Local Feature Selection for Data Classification
N. Armanfard (2016)
10.1007/s40484-017-0092-7
Elastic restricted Boltzmann machines for cancer data analysis
Sai Zhang (2017)
10.1093/bioinformatics/btx532
clustComp, a bioconductor package for the comparison of clustering results
A. Torrente (2017)
10.1016/j.jbiosc.2017.05.015
Orthogonal partial least squares/projections to latent structures regression-based metabolomics approach for identification of gene targets for improvement of 1-butanol production in Escherichia coli.
Katsuaki Nitta (2017)
Department of Pathology, Thom as Jeffe rson University, Identific ation of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
J. Herschkowitz (2007)
10.1109/ICINNOVCT.2010.5440095
Classification of cancer gene expressions from micro-array analysis
E. Venkatesh (2010)
10.19026/RJASET.9.2601
Breast Cancer Detection Using Multi-resolution Diatric Microarray Curvelet Transform
M. Varalakshmi (2015)
10.1016/S0002-9440(10)63435-9
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays.
M. Bibikova (2004)
10.1109/TCBB.2011.129
DICLENS: Divisive Clustering Ensemble with Automatic Cluster Number
Selim Mimaroglu (2012)
in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared withT Cells fromHealthy Volunteers
C. Learn (2006)
10.1016/j.thromres.2011.06.003
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism.
D. Lewis (2011)
10.1016/J.CHEMOLAB.2012.12.004
A model population analysis method for variable selection based on mutual information
Xu-Xia Long (2013)
10.1371/journal.pone.0104314
Learning a Weighted Meta-Sample Based Parameter Free Sparse Representation Classification for Microarray Data
B. Liao (2014)
10.1186/1755-8794-7-S2-S5
Supervised redundant feature detection for tumor classification
Xue-Qiang Zeng (2014)
10.1186/bcr3166
ER and PR signaling nodes during mammary gland development
Tamara Tanos (2012)
10.1016/J.SURG.2004.05.040
Genomic approaches in cancer biology.
E. Matros (2004)
10.1007/978-0-387-09463-2_11
Estrogen receptor phenotypes defined by gene expression profiling.
M. Kok (2009)
10.1007/s10549-007-9716-3
Consensus genes of the literature to predict breast cancer recurrence
Martin Lauss (2007)
10.1016/j.mbs.2013.07.011
A biased random-key genetic algorithm for data clustering.
P. Festa (2013)
10.1245/ASO.2003.05.031
The Future of Cancer Management: Translating the Genome, Transcriptome, and Proteome
T. Yeatman (2003)
10.1038/ng1167
Gene expression phenotypic models that predict the activity of oncogenic pathways
E. Huang (2003)
10.1038/onc.2011.486
Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature
S. E. Franks (2012)
Advances in breast cancer therapy and chemoprevention: current strategies and new approachesArticle
Brittney-Shea Herbert (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar